SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure
On January 21, 2020, the Company issued a press release announcing that its shares of common stock have been approved for listing on the Nasdaq Capital Market. Trading on the exchange is expected to commence on January 23, 2020 under the ticker symbol “SWKH.”
The information in Item 7.01 of this Current Report on Form 8-K, including the press release, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Item 7.01 of this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
| 99.1 | Press Release of SWK Holdings Corporation, dated January 21, 2020 Announcing Uplisting to Nasdaq Capital Market |
SWK Holdings Corp Exhibit
EX-99.1 2 e20049_ex99-1.htm SWK Holdings Corporation Announces Uplisting to Nasdaq Capital Market Trading to begin on January 23,…
To view the full exhibit click here
About SWK HOLDINGS CORPORATION (OTCMKTS:SWKH)
SWK Holdings Corporation is a healthcare capital provider. The Company offers financing solutions to a range of life science companies, institutions and inventors. The Company’s focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Company, through its subsidiary SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. It focuses to fund transactions through its own working capital, as well as by building its asset management business by raising additional third party capital to be invested alongside its capital. The Company evaluates and invests in a range of healthcare related companies and products.
